NovoCure Ltd (NASDAQ: NVCR) is -23.05% lower on its value in year-to-date trading and has touched a low of $11.70 and a high of $34.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The NVCR stock was last observed hovering at around $24.18 in the last trading session, with the day’s loss setting it -1.25%.
Currently trading at $22.93, the stock is -11.24% and -16.15% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.87 million and changing -5.17% at the moment leaves the stock 13.14% off its SMA200. NVCR registered 67.01% gain for a year compared to 6-month gain of 17.83%. The firm has a 50-day simple moving average (SMA 50) of $27.2289 and a 200-day simple moving average (SMA200) of $20.2125.
The stock witnessed a -22.69% loss in the last 1 month and extending the period to 3 months gives it a 38.22%, and is -10.11% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.65% over the week and 4.58% over the month.
NovoCure Ltd (NVCR) has around 1453 employees, a market worth around $2.48B and $577.74M in sales. Profit margin for the company is -25.93%. Distance from 52-week low is 95.98% and -32.82% from its 52-week high. The company has generated returns on investments over the last 12 months (-31.27%).
The EPS is expected to grow by 33.55% this year
330.0 institutions hold shares in NovoCure Ltd (NVCR), with institutional investors hold 96.53% of the company’s shares. The shares outstanding are 108.10M, and float is at 96.95M with Short Float at 5.03%. Institutions hold 87.24% of the Float.
The top institutional shareholder in the company is FMR LLC with over 16.14 million shares valued at $276.51 million. The investor’s holdings represent 15.0482 of the NVCR Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 12.13 million shares valued at $207.83 million to account for 11.3106 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 11.7 million shares representing 10.904 and valued at over $200.36 million, while VANGUARD GROUP INC holds 10.3736 of the shares totaling 11.13 million with a market value of $190.61 million.
NovoCure Ltd (NVCR) Insider Activity
The most recent transaction is an insider sale by Paravasthu Mukund, the company’s Chief Operating Officer. SEC filings show that Paravasthu Mukund sold 2,160 shares of the company’s common stock on Jan 11 ’25 at a price of $26.81 per share for a total of $57906.0. Following the sale, the insider now owns 31437.0 shares.
Still, SEC filings show that on Jan 02 ’25, WILHELMUS C. GROENHUYSEN (Officer) Proposed Sale 266,085 shares at an average price of $29.80 for $7.93 million. The insider now directly holds shares of NovoCure Ltd (NVCR).
